access

Patients

pharmaphorum podcast Episode 244, Jeff Harper, Intelliguard

On addressing drug waste and ensuring access, with Jeff Harp...

The rising cost of drugs in 2025 was driven by several factors, including inflation, supply chain issues, and the demand for specialty drugs.

News

UK will cover transport costs for children with cancer

Families of young people with cancer in England will have the costs of travelling to medical appointments covered under a new funding scheme.

News

HCP with a small pile of pills in their palm

NICE relents, ending postcode access to prostate cancer drug

Men in England with high-risk prostate cancer will soon be able to get treatment with a drug available in Scotland and Wales for almost three years.

Sales & Marketing

Pharmacist with patient, explaining prescription

Why pharmacy-based engagement is pharma’s untapped adherence...

Pharma companies can work alongside pharmacists to deliver personalised outreach that informs patient treatment decisions and drives adherence.

Oncology

The cancer community must seize the opportunity of the Natio...

With the government’s National Cancer Plan due for publication this autumn, we have an opportunity to fundamentally improve how we deliver innovation.

Market Access

Unlocking oncology access: What the OECD findings mean for m...

New policies are shaping the market access landscape, such as the introduction of the EU HTA for oncology medicines.